Ruth is a HEOR, healthcare services, academic research, and market access professional with over 15 years of experience leading European and global teams. Most recently, Ruth is the EMEA HEOR lead for Cepheid, a Danaher company. Prior to that, she was the Global Head of Health Economics and Value Assessment for Rare Diseases at Sanofi, leading HEOR and access strategies for more than 15 products across multiple therapeutic areas, with a particular focus on product lifecycle management. Ruth’s diverse career path includes roles as an academic researcher, member of the NICE evidence review group, and positions within the National Health Service (NHS). She has authored over 65 peer-reviewed scientific articles in prestigious journals such as The Lancet and The BMJ. Ruth holds a PhD in Health Economics from the University of Warwick and a Master of Public Health from the University of Sheffield.